Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.61 |
| ▸ | CTSB | P07858 | 1/20 | 0.50 |
| ▸ | CTSH | P09668 | 1/20 | 0.50 |
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | CCR1 | P32246 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30894755 | 0.98 | KMT2A (0.59) | KMT2AOPRK1CTSBCTSHMETAP2 | |
| Hydrochloric Acid SCHEMBL11130882 | 0.98 | KMT2A (0.59) | KMT2AOPRK1CTSBCTSHMETAP2 | |
| SCHEMBL23714059 | 0.82 | KMT2A (0.46) | KMT2AOPRK1CTSBCTSHMETAP2 | |
| SCHEMBL3463680 | 0.80 | KMT2A (0.57) | KMT2AOPRK1CTSBCTSHMETAP2 | |
| SCHEMBL3275602 | 0.79 | KMT2A (0.77) | KMT2AOPRK1CTSBCTSHMETAP2 | |
| SCHEMBL1461233 | 0.79 | KMT2A (0.56) | KMT2AOPRK1CTSBCTSHMETAP2 | |
| SCHEMBL10616153 | 0.78 | PDE10A (0.39) | KMT2AOPRK1KDM4EHSD17B10RAB9A | |
| SCHEMBL7171554 | 0.77 | KMT2A (0.74) | KMT2AOPRK1CTSBCTSHMETAP2 | |
| SCHEMBL4703454 | 0.77 | KMT2A (0.67) | KMT2AOPRK1CTSBCTSHMETAP2 | |
| SCHEMBL7692195 | 0.77 | KMT2A (0.67) | KMT2AOPRK1CTSBCTSHMETAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2382193-A1 | PPAR AGONIST COMPOSITIONS AND METHODS OF USE | Biopharmed (FR) | 2011-11-02 | — | — | EP | disclosed |
| US-20110251238-A1 | PPAR AGONIST COMPOSITIONS AND METHODS OF USE | BIOPHARMED (FR) | 2011-10-13 | — | — | US | disclosed |
| WO-2010073235-A1 | PPAR AGONIST COMPOSITIONS AND METHODS OF USE | BIOPHARMED (FR) | 2010-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251238-A1 | PPAR AGONIST COMPOSITIONS AND METHODS OF USE | PPARA, PPARG, PPARD | KMT2A 3167/4885OPRK1 69/4885CTSB 1262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.